Manifestations of chronic disease during pregnancy

JAMA

Volumn 294, Issue 21, 2005, Pages 2751-2757

  Kaaja, Risto J ^a   Greer, Ian A ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANEURYSM; ARTERIOVENOUS MALFORMATION; AUTOIMMUNE DISEASE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLELITHIASIS; CHRONIC DISEASE; CORONARY ARTERY DISEASE; DISEASE COURSE; DYSLIPIDEMIA; ETHNOLOGY; FETOPLACENTAL UNIT; GLOMERULOPATHY; HUMAN; HYPERVOLEMIA; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INSULIN RESISTANCE; INTRAHEPATIC CHOLESTASIS; MATERNAL HYPERTENSION; MEDICAL LITERATURE; MEDLINE; METABOLIC DISORDER; METABOLIC SYNDROME X; MULTIPLE SCLEROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; STROKE; TH1 CELL; TH2 CELL; THROMBOPHILIA; VEIN THROMBOSIS;

EID: 28844472592     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.294.21.2751     Document Type: Review

References (99)

1. Redman CW. Hypertension in pregnancy. In: De Swiet M, ed. Medical Disorders in Obstetric Practice. 3rd ed. Oxford, England: Blackwell Science; 1995:182-225.
2. Stirling Y, Woolf L, North WR, et al. Haemostasis in normal pregnancy. Thromb Haemost. 1984;52:176.
3. Clark P, Brennand J, Conkie JA, McCall F, Greer IA, Walker ID. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost. 1998;79:1166-1170.
4. Greer IA. Thrombophilia: implications for pregnancy outcome. Thromb Res. 2003;109:73-81.
5. Ryan EA. Hormones and insulin resistance during pregnancy. Lancet. 2003;362:1777-1778.
6. Clark DA, Arck PC, Chaouat G. Why did your mother reject you? immunogenetic determinants of the environmental selective pressure expressed at the uterine level. Am J Reprod Immunol. 1999;41:5-22.
7. Soldan SS, Alavarez Retuerto AI, Sicotte NL, Voskuhl RR. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J Immunol. 2003;171:6267-6274.
8. Letsky EA. Blood volume, haematinics, anaemia. In: De Swiet M. Medical Disorders in Obstetric Practice. 3rd ed. Oxford, England: Blackwell Science; 1995:33-70.
9. Rovinsky JJ, Jaffin H. Cardiovascular hemodynamics in pregnancy, I: blood and plasma volumes in multiple pregnancy. Am J Obstet Gynecol. 1965;93:1-13.
10. Dorup I, Skajaa K, Sorensen KE. Normal pregnancy is associated with enhanced endothelium-dependent flow-mediated vasodilatation. Am J Physiol. 1999;276:H821-H825.
11. Suzuki Y, Hattori T, Kajikuri J, Yamamoto T, Suzumori K, Itoh T. Reduced function of endothelial prostacyclin in human omental resistance arteries in preeclampsia. J Physiol. 2002;545:269-277.
12. Khalil RA, Granger JP. Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol. 2002;283:R29-R45.
13. Kaaja R, Laivuori H, Laakso M, Tikkanen MJ, Ylikorkala O. Evidence of a state of increased insulin resistance in preeclampsia. Metabolism. 1999;48:892-896.
14. Ryan EA, Enns L. Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab. 1988;67:341-347.
15. Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care. 1998;21(suppl 2):B161-B167.
16. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352:2477-2486.
17. Lauenborg J, Hansen T, Moller D, et al. Increasing incidence of diabetes after gestational diabetes. Diabetes Care. 2004;27:1194-1199.
18. Kjos SL, Peters RK, Xiang A, Henry OA, Montoro M, Buchanan TA. Predicting future diabetes in Latino women with gestational diabetes: utility of early postpartum glucose tolerance testing. Diabetes. 1995;44:586-591.
19. Kim C, Newton K, Knopp R. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25:1862-1868.
20. Clark CM, Qui C, Mamerman B, et al. Gestational diabetes: should it be added to the syndrome of insulin resistance? Diabetes. 1997;20:867-871.
21. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest. 2005;115:485-491.
22. Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab. 2003;88:2393-2398.
23. Kaaja R, Tikkanen M, Viinikka L, Ylikorkala O. Serum lipoproteins, insulin and urinary excretion of prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol. 1995;85:353-356.
24. Schobel HP. Preeclampsia-a state of sympathetic overactivity. N Engl JMed. 1996;335:1480-1485.
25. Kaaja R, Moore P, Yandle T, Ylikorkala O, Frampton C, Nicholls G. Diurnal patterns of vasoactive hormones in early stage of pre-eclampsia. Hypertens Pregnancy. 1999;18:173-187.
26. Greer IA, Haddad NG, Dawes J, Johnstone FD, Calder AA. Neutrophil activation in pregnancy-induced hypertension. Br J Obstet Gynaecol. 1989;96:978-982.
27. Laivuori H, Tikkanen MJ, Ylikorkala O. Hyperinsulinemia 17 years after preeclamptic first pregnancy. J Clin Endocrinol Metab. 1996;81:2908-2911.
28. Laivuori H, Kaaja R, Rutanen E-M, Viinikka L, Ylikorkala O. Evidence of high circulating testosterone in women with prior preeclampsia. J Clin Endocrinol Metab. 1998;83:344-347.
29. Sattar N, Ramsay J, Crawford L, Cheyne H, Greer IA. Classic and novel risk factor parameters in women with a history of preeclampsia. Hypertension. 2003;42:39-42.
30. He S, Silveira A, Hamsten A, Blomback M, Bremme K. Haemostatic, endothelial and lipoprotein parameters and blood pressure levels in women with history of preeclampsia. Thromb Haemost. 1999;81:538-542.
31. Chambers JC, Fusi L, Malik IS, Hskard DO, De Swiet M, Kooner JS. Association of maternal endothelial dysfunction with preeclampsia. JAMA. 2001;285:1607-1612.
32. Jonsdottir LS, Arngrimsson R, Geirsson RT, Sigvaldason H, Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand. 1995;74:772-776.
33. Sattar N, Greer I. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ. 2002;325:157-160.
34. Rodie V, Freeman DJ, Sattar N, Greer IA. Preeclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis. 2004;175:189-202.
35. Haukkamaa L, Salminen M, Laivuori H, Leinonen H, Hiilesmaa V, Kaaja R. Risk for subsequent coronary artery disease after preeclampsia. Am J Cardiol. 2004;93:805-808.
36. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk for ischaemic heart disease: a retrospective cohort study of 129 290 births. Lancet. 2001;357:2002-2006.
37. Wilson B, Watson MS, Prescott GJ, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ. 2003;326:845.
38. Kuller JA, Dandrea NM, McMahon MJ. Renal biopsy and pregnancy. Am J Obstet Gynecol. 2001;184:1093-1096.
39. Jungers P, Chauveau D. Pregnancy in renal disease. Kidney Int. 1997;52:871-885.
40. Felker GM, Hu W, Hare JM, Hruban RH, Baughman KL, Kasper EK. The spectrum of dilated cardiomyopathy: the Johns Hopkins experience with 1278 patients. Medicine. 1999;78:270-283.
41. Stoodley MA, Macdonald RL, Weir BK. Pregnancy and intracranial aneurysms. Neurosurg Clin N Am. 1998;9:549-556.
42. Horton JC, Chambers WA, Lyons SL, Adams RD, Kjellberg RN. Pregnancy and the risk of hemorrhage from cerebral arteriovenous malformations. Neurosurgery. 1990;27:867-872.
43. Mostello D, Catlin TK, Roman L, Holcomb WL, Leet T. Preeclampsia in the parous woman: who is at risk? Am J Obstet Gynecol. 2002;187:425-429.
44. Pearson GD, Veille J-C, Rahimtoola S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA. 2000;283:1183-1188.
45. Robertson L, Greer I. Thromboembolism in pregnancy. Curr Opin Obstet Gynecol. 2005;17:113-116.
46. Kupferminc MJ. Thrombophilia and pregnancy. Reprod Biol Endocrinol. 2003;1:111-133.
47. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 suppl):627S-644S.
48. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1998;21(suppl 1):S5-S19.
49. Sorensen TK, Williams MA, Lee IM, Dashow EE, Thompson ML, Luthy DA. Recreational physical activity during pregnancy and risk of preeclampsia. Hypertension. 2003;41:1273-1280.
50. Conway DL, Langer O. Effects of new criteria for type 2 diabetes on the rate of postpartum glucose intolerance in women with gestational diabetes. Am J Obstet Gynecol. 1999;181:610-614.
51. Benjamin SM, Valdez R, Geiss LS, Rolka DB, Narayan KM. Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention. Diabetes Care. 2003;26:645-649.
52. Messerli FH, Grossman E, Leonetti G. Antihypertensive therapy and new onset diabetes. J Hypertens. 2004;22:1845-1847.
53. Lensen R, Rosendaal F, Vandenbroucke J, Bertina R. Factor V Leiden: the venous thrombotic risk in thrombophilic families. Br J Haematol. 2000;110:939-945.
54. Ostensen M. Sex hormones and pregnancy in rheumatoid arthritis and systemic lupus erythematosus. Ann N Y Acad Sci. 1999;876:131-143.
55. Martinelli I, De Stefano V, Taioli E, Paciaroni K, Rossi E, Mannucci PM. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium. Thromb Haemost. 2002;87:791-795.
56. Wu O, Robertson L, Langhorne P, et al. Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review: the Thrombosis Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Thromb Haemost. 2005;94:17-25.
57. Robertson L, Wu O, Langhorne P, et al. Thrombophilia and pregnancy: a systematic review. Br J Haematol. In press.
58. Al-Shammri S, Rawoot P, Azizich F, et al. Th1/Th2 cytokine patterns and clinical profiles during and after pregnancy in women with multiple sclerosis. J Neurol Sci. 2004;222:21-27.
59. Muller AF, Drexhage HA, Berghout A. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev. 2001;22:605-630.
60. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interaction in the maternalfetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today. 1993;14:353-356.
61. Oka M. Effect of pregnancy on the onset and course of rheumatoid arthritis. Ann Rheum Dis. 1953;12:227-229.
62. Felbo M, Snorrason E. Pregnancy and the place of therapeutic abortion in rheumatoid arthritis. Acta Obstet Gynecol Scand. 1961;40:116-127.
63. Silman A, Kay A, Brennan P. Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis Rheum. 1992;35:152-155.
64. Watanabe M, Iwatani Y, Kaneda T, et al. Changes in T, B and NK lymphocyte subsets during and after normal pregnancy. Am J Reprod Immunol. 1997;37:368-377.
65. Poser S, Poser W. Multiple sclerosis and gestation. Neurology. 1983;33:1422-1427.
66. Confavreux C, Hutchinson M, Hours MM, et al; Pregnancy in Multiple Sclerosis Group. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med. 1998;339:285-291.
67. Ramsay I. Thyroid disease. In: De Swiet M, ed. Medical Disorders in Obstetric Practice. 3rd ed. Oxford, England: Blackwell Science; 1995:459-482.
68. Jansson R, Bernander S, Karlsson A, Levin K, Nilsson G. Autoimmune thyroid dysfunction in the postpartum period. J Clin Endocrinol Metab. 1984;58:681-687.
69. Kordonouri O, Hartmann R, Deiss D, Wilms M, Gruters-Kieslich A. Natural course of autoimmune thyroiditis in type 1 diabetes association with gender, age, diabetes, duration and puberty. Arch Dis Child. 2005;90:411-414.
70. Ginsberg J, Walfish PG. Post-partum transient thyrotoxicosis with painless thyroiditis Lancet. 1977;1:1125-1128.
71. Amino N, Mori H, Iwatani Y, et al. High prevalence of transient postpartum thyrotoxicosis and hypothyroidism. N Engl J Med. 1982;306:849-852.
72. Othman S, Phillips DI, Parkes AB, et al. A long-term follow-up of postpartum thyroiditis. Clin Endocrinol (Oxf). 1990;32:559-564.
73. Buyon JP. Neonatal lupus syndromes. In: Lahita R, ed. Systemic Lupus Erythematosus. 3rd ed. San Diego, Calif: Academic Press; 1999:337-359.
74. Julkunen H, Eronen M. Long-term outcome of mothers of children with isolated heart block in Finland. Arthritis Rheum. 2001;44:647-652.
75. Lambert N, Nelson JL. Microchimerism in autoimmune disease: more questions than answers? Autoimmun Rev. 2003;2:133-139.
76. Davison J, Baylis C. Renal disease. In: De Swiet M, ed. Medical Disorders in Obstetric Practice. 3rd ed. Oxford, England: Blackwell Science; 1995:226-305.
77. Ihle BU, Long P, Oats J. Early onset preeclampsia: recognition of underlying renal disease. BMJ. 1987;294:79-81.
78. Bernheim J, Plotkin E, Bernheim J, Korzets Z. It looks like, it smells like, but is it just pre-eclampsia? Nephrol Dial Transplant. 2005;20:451-452.
79. Barrett JM, Van Hooydonk JE, Boehm FH. Pregnancy-related rupture of arterial aneurysm. Obstet Gynecol Surv. 1982;37:557-566.
80. Popham P, Buettner A. Arterial aneurysm of the lienorenal axis during pregnancy. Int J Obstet Anesth. 2003;12:117-119.
81. Bultmann BD, Klingel K, Nabauer M, Wallwiener D, Kardolf R. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol. 2005;193:363-365.
82. Sundstrom JB, Fett JD, Carraway RD, Ansari AA. Is peripartum cardiomyopathy an organ-specific autoimmune disease? Autoimmun Rev. 2002;1:73-77.
83. Heider AL, Kuller JA, Strauss RA, Wells SR. Peripartum cardiomyopathy: a review of the literature. Obstet Gynecol Surv. 1999;54:526-531.
84. Laatikainen T, Ikonen E. Fetal prognosis in obstetric hepatosis. Ann Chir Gynaecol Fenn. 1975;64:155-164.
85. Savander M, Ropponen A, Avela K, et al. Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy. Gut. 2003;52:1025-1029.
86. Eloranta M-L, Heinonen S, Mononen T, Saarikoski S. Risk of obstetric cholestasis in sisters of index patients. Clin Genet. 2001;60:42-45.
87. Dalen E, Westerholm B. Occurrence of hepatic impairment in women jaundiced by oral contraceptives and in their mothers and sisters. Acta Med Scand. 1974;195:459-463.
88. Rosmorduc O, Hermelin B, Poupon R.MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Gastroenterology. 2001;120:1459-1467.
89. Jacquemin E, Cresteil D, Manouvrier S, Boute O, Hadchouel M. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet. 1999;353:210-211.
90. Peters RK, Kjos SL, Xiang A, Buchanan TA. Longterm diabetogenic effect of single pregnancy in women with gestational diabetes. Lancet. 1996;347:227-230.
91. Metzger BE, Cho NH, Roston SM, Radvany R. Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care. 1993;16:1598-1605.
92. Kohno K, Matsuoka H, Takenaka K, et al. Depressor effect by exercise training is associated with amelioration of hyperinsulinemia and sympathetic overactivity. Intern Med. 2000;39:1013-1019.
93. Shepard DR, Ineid H, Thacker HL. Gender, hyperlipidemia and coronary artery disease. Compr Ther. 2003;29:7-17.
94. LaRosa JC. What do statins tell us? Am Heart J. 2002;144:S21-S26.
95. Ridker PM. High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. Am J Cardiol. 2003;92:17K-22K.
96. Wilson PW, Kannel WB, Silbershatz H, D'Agostino RB. Clustering of metabolic factors and coronary artery disease Arch Intern Med. 1999;159:1104-1109.
97. Bugiardini R, Manfrini O, Pizzi C, Fontana F, Morgagni G. Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation. 2004;109:2518-2523.
98. Redberg RF, Shaw L. Diagnosis of coronary artery disease in women. Prog Cardiovasc Dis. 2003;46:239-258.
99. Vig S, Chitolie A, Sleight S, et al. Prevalence and risk of thrombophilia defects in vascular patients. Eur J Vasc Endovasc Surg. 2004;28:124-131.